Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer

<h4>Aims</h4> <p>Gastrointestinal toxicity impedes dose escalation in chemoradiotherapy for hepatobiliary malignancies. Toxicity risk depends on clinical and radiotherapy metrics. We aimed to identify predictive factors using data from two prospective phase II clinical trials of l...

Full description

Bibliographic Details
Main Authors:	Holyoake, DLP, Warren, DR, Hurt, C, Aznar, M, Partridge, M, Mukherjee, S, Hawkins, MA
Format:	Journal article
Language:	English
Published:	Elsevier 2018

Similar Items

Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy
by: Holyoake, D, et al.
Published: (2017)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
by: Holyoake, D, et al.
Published: (2016)

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
by: Holyoake, D, et al.
Published: (2017)

Meta-analysis of toxicity and small-bowel radiotherapy dose-volume: “omnibus consequentia”
by: Holyoake, D, et al.
Published: (2018)

Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours?
by: Warren, S, et al.
Published: (2016)

Systematic review and meta-analysis of small bowel dose–volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy
by: Holyoake, D, et al.
Published: (2019)

Pixel-based analysis of stomach dose-surface maps to improve toxicity predictions in gastrointestinal radiotherapy
by: Witztum, A, et al.
Published: (2017)

Correlation of 18F-fluorodeoxyglucose positron emission tomography parameters with patterns of disease progression in locally advanced pancreatic cancer after definitive chemoradiotherapy
by: Wilson, J, et al.
Published: (2017)

EP-1721: Feature extraction from duodenal dose surface maps to predict toxicity in pancreatic chemoradiation
by: Witztum, A, et al.
Published: (2016)

Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.
by: Warren, S, et al.
Published: (2014)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
by: Mukherjee, S, et al.
Published: (2024)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
by: Warren, S, et al.
Published: (2015)

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer
by: Warren, S, et al.
Published: (2017)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: A radiobiological investigation
by: Carrington, R, et al.
Published: (2015)

SU-F-T-108: Texture analysis for toxicity prediction from dose surface maps.
by: Witztum, A, et al.
Published: (2016)

Stomach and duodenum dose–volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy
by: Sara Broggi, et al.
Published: (2023-01-01)

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.
by: Holyoake, D, et al.
Published: (2016)

Modelling normal tissue toxicity in pancreatic chemoradiotherapy
by: Witztum, A
Published: (2018)

Investigating the toxicity and safety of radiotherapy for pancreatic cancer
by: Holyoake, D
Published: (2018)

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
by: Wilson, J, et al.
Published: (2017)

Comparing dose-volume histogram and radiobiological endpoints for ranking intensity-modulated arc therapy and 3D-radiotherapy treatment plans for locally-advanced pancreatic cancer.
by: Warren, S, et al.
Published: (2013)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2018-07-01)

Conformity analysis of target-volume definition for margin-directed boost in pancreatic cancer SBRT
by: Holyoake, D, et al.
Published: (2016)

SU-D-BRA-06: Duodenal interfraction motion with abdominal compression.
by: Witztum, A, et al.
Published: (2016)

Radiomics of skeletal muscle helps to predict gastrointestinal toxicity in locally advanced rectal cancer patients receiving neoadjuvant chemoradiotherapy
by: Wang Yang, et al.
Published: (2024-01-01)

Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction.
by: Guichao Li, et al.
Published: (2013-01-01)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
by: Mukherjee, S, et al.
Published: (2013)

Gastrointestinal stromal tumors stomach cese
by: Popović Miroslav, et al.
Published: (2014-01-01)

Editorial: Advances in genetics and molecular diagnosis in colorectal, stomach, and pancreatic cancer
by: Carlos Alberto Vaccaro, et al.
Published: (2022-12-01)

[Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis].
by: Brunner, T
Published: (2012)

Oral contrast improves soft tissue matching in image guided radiation therapy for gastrointestinal (GI) tumors
by: Chu, K, et al.
Published: (2016)

Oral contrast improves soft tissue matching in image guided radiation therapy for gastrointestinal (GI) tumors
by: Chu, K, et al.
Published: (2016)

A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity.
by: Gulliford, S, et al.
Published: (2010)

Dose–Volume and Radiobiological Model-Based Comparative Evaluation of the Gastrointestinal Toxicity Risk of Photon and Proton Irradiation Plans in Localized Pancreatic Cancer Without Distant Metastasis
by: Vijay P. Raturi, et al.
Published: (2020-10-01)

Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
by: Ayaka Ogawa, et al.
Published: (2023-06-01)

The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
by: Zhaoqing Tang, et al.
Published: (2022-11-01)

Carcinoma of the oesophagus and stomach : upper gastrointestinal disease /
by: 402441 Fawcett, A. N.
Published: (1982)

Laparoscopic management of stomach gastrointestinal stromal tumours
by: Iqbal Saleem Mir, et al.
Published: (2018-03-01)

Synchronous adenocarcinoma and gastrointestinal stromal tumor in the stomach
by: Narasimhamurthy Mohana, et al.
Published: (2010-01-01)

Gastrointestinal stromal tumor of the stomach. Case report
by: P.R. Arellano-López, et al.
Published: (2018-10-01)